FILE PHOTO: Vials of the AstraZeneca coronavirus disease (COVID-19) vaccine are seen, as AstraZeneca vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Milan, Italy, March 19, 2021. REUTERS/Flavio Lo Scalzo
(Reuters) - Many countries are resuming the use of the Anglo-Swedish drugmaker's vaccine after the European Medicines Agency (EMA) and the World Health Organization (WHO) said the benefits outweighed the risks following investigations into reports of blood clots.
At least 17 countries had suspended or delayed use after reports of hospitalisations with clotting issues and bleeding, while Asia is accelerating inoculations.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
